department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

LATANOPROST · pharmadog

pharmadog
drugs
LATANOPROST

drug

patient view →

LATANOPROST

Preclinicalupdated 2mo ago

by Rebio Technologies Ltd

Preclinical

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

LATANOPROST

generic

LATANOPROST

indication

Open-Angle Glaucoma

phase

preclinical

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

🐶 often sniffed alongside

top 8

tagApproval12 co-mentions · 6 sources
druglatanoprost SR8 co-mentions · 8 sources
drugXalatan8 co-mentions · 8 sources
companyEpic Pharma LLC5 co-mentions · 5 sources
companyGlenmark Pharmaceuticals Ltd1 co-mentions · 1 sources
companyMankind Pharma Ltd1 co-mentions · 1 sources
tagDermatology1 co-mentions · 1 sources
tagRecall1 co-mentions · 1 sources

Trials studying LATANOPROST

phase3Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reductioncompletedn=489
phase3Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular Hypertensionrecruitingn=60
phase424-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patientsrecruitingn=30
phase4Rocklatan vs Latanoprost Post-DSLTnot yet recruitingn=36
phase1Open Label, Sequential-dose Study of PA5108 Latanoprost FA SR Ocular Implant for Mild-moderate Glaucomacompletedn=37
phase2Next Generation Rocklatancompletedn=426
phase3MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertensioncompletedn=696
phase3Phase 3 Trial of NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertensioncompletedn=691

more trials →